Login to Your Account

FDA Tackles Nanotechnology Impact on Drug Regulation

By Marie Powers
Staff Writer

Friday, August 10, 2012

While the rest of the biotech world seems to embrace the arrival of nanotechnology in drug development, the FDA is still seeking to understand the nuances of products that contain nanoscale materials.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription